Adaptive Biotechnologies
ADPT
ADPT
248 hedge funds and large institutions have $4.58B invested in Adaptive Biotechnologies in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 99 increasing their positions, 77 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
12% less call options, than puts
Call options by funds: $23M | Put options by funds: $26M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
32% less capital invested
Capital invested by funds: $6.75B → $4.58B (-$2.17B)
Holders
248
Holding in Top 10
6
Calls
$23M
Puts
$26M
Top Buyers
| 1 | +$199M | |
| 2 | +$104M | |
| 3 | +$34.6M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$23.7M |
| 5 |
CC
Casdin Capital
New York
|
+$23.6M |
Top Sellers
| 1 | -$120M | |
| 2 | -$89.6M | |
| 3 | -$56.1M | |
| 4 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$43.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$38.8M |